Protein tyrosine phosphatase non-receptor type 1 and type 2 inhibitor (iTeos Therapeutics)

N/A

Report date: 2025/06/30 16:21:49
NME

Base Information

Drug NameProtein tyrosine phosphatase non-receptor type 1 and type 2 inhibitor (iTeos Therapeutics)
Drug Alias NamePTPN1/2 inhibitor
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitorsTyrosine-protein phosphatase non-receptor type 2 inhibitors
TargetsProtein-tyrosine phosphatase 1BTyrosine-protein phosphatase non-receptor type 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesITeos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesITeos Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A